Clinical trial
A Study of Anginera In Patients Undergoing Coronary Artery Bypass Graft (CABG)…
NCT00364390 · Theregen, Inc., Industry · Unknown status
Key facts
| NCT number | NCT00364390 |
|---|---|
| Title | A Study of Anginera In Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery |
| Official title | A Phase I Open Label Pilot Study to Evaluate the Safety, Efficacy and Tolerability of Anginera for Adults With Left Ventricular Dysfunction AND Reversible Myocardial Ischemia Undergoing CABG Surgery |
| Lead sponsor | Theregen, Inc., Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Anginera, a human tissue replacement therapy |
| Enrollment | 12 |
| Start date | Apr 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Aug 15, 2006 |
| Last update posted | Mar 30, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: